Review of second-line chemotherapy for advanced gastric adenocarcinoma.
about
Critical appraisal of trastuzumab in treatment of advanced stomach cancerSecond-line treatment of metastatic gastric cancer: Current options and future directionsChemotherapy beyond second-line in advanced gastric cancerStrategies and Advancements in Harnessing the Immune System for Gastric Cancer ImmunotherapyDocetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.Phase II study of sunitinib as second-line treatment for advanced gastric cancer.A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancerOxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancerEconomic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer.Prognostic factors of second and third line chemotherapy using 5-fu with platinum, irinotecan, and taxane for advanced gastric cancerFirst-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status.A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance statusSecond-line chemotherapy for patients with advanced gastric cancer: who may benefit?Pharmacotherapy for oesophagogastric cancer.Trastuzumab for gastric cancer.Second-line chemotherapy for gastric cancer: a new issue lies ahead in global trials.Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea.Design of precise third-line therapy for gastric cancer: target or chemotherpy?Treatment of patients with advanced gastric cancer: experience from an Indian tertiary cancer center.Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric CancerPhase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer.Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum.Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.
P2860
Q24604411-7DA6EED2-1521-4331-9222-4B2A3F803B2EQ26778027-F8C72F0C-F769-4D89-92A4-9D037C7380D1Q26798288-9197DFF5-7F88-45BF-B05A-38594E230E94Q26823515-C79E98AA-7FA9-4136-8593-454696A40117Q33386661-51706700-541B-46A8-B663-18E76FE922B2Q33389519-F7940520-B02C-4981-8D96-901364018C6CQ33428751-EDB07E96-E7D9-4C35-B45A-9B97D03AB421Q33766456-E67A64FA-B0FD-4096-B099-BBC39B4F36E1Q35068015-2EF07A0C-8F70-4F12-86A2-727B5DC48058Q35233550-B5A40B0F-77D3-415C-AF02-01CE3CC7806DQ35661060-7166F352-3BAE-4605-8000-2132CECAB1A2Q36409085-F4C49944-6198-4519-AD2E-D2C06B74D236Q36610995-91988097-3360-4B26-89CF-B5D225C80393Q36964966-A14E28E8-CE7A-4E58-9386-338EF2723F30Q37011966-36A412C5-1E7C-4CE1-9BEB-0BF536BF3330Q37633540-897E4853-3675-4A8E-81B5-82F30A91B5F7Q37904800-BAD1DDE7-714B-4A80-9F09-97B0F1DBEB0BQ39400428-9771BB42-AD83-4560-9E24-33374A1AEF90Q43162843-E7D8A381-2526-46F5-B448-2ED592A4141EQ45218658-61BD46A2-C1F0-4086-AB13-355657106BCAQ46708594-C0B31E8A-03DD-4DFD-AEC2-7E79FD76E7A4Q48208260-A51EE9C9-BE96-4E94-B4A6-EAA2BB613297Q49645479-289111F2-0B95-43C0-B960-2E87BBE04DDAQ51047134-727BB43D-4A1A-4FCB-94E6-56C94A1EC9EBQ51048811-1BD627A9-57D4-4811-ABEF-8660B35D50EAQ51215133-1C026E5C-DA11-40E5-83CD-F5932B2F37DA
P2860
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
@ast
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
@en
type
label
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
@ast
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
@en
prefLabel
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
@ast
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
@en
P2093
P1433
P1476
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
@en
P2093
P356
10.1016/J.CLON.2004.10.006
P577
2005-04-01T00:00:00Z